Back to User profile » Professor Xiaojing Xing

Paper published by Professor Xiaojing Xing:


Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors

Fang J, Jiang O, Li W, Lin J, Fang M, Li Q, Zhao W, Wang K, Shi H, Chen Z, Yu J, Xing X, Zhao M, Liu A, Wang W, Han Z, Xiang S, Zhang X, Li J, Zhou C

Drug Design, Development and Therapy 2025, 19:10423-10435

Published Date: 24 November 2025